Medtronic, Inc.  

(Public, NYSE:MDT)   Watch this stock  
Find more results for Richard Powell�
63.28
-0.09 (-0.14%)
After Hours: 63.28 0.00 (0.00%)
Jul 24, 6:28PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 63.21 - 63.97
52 week 51.22 - 65.50
Open 63.62
Vol / Avg. 9.66M/11.81M
Mkt cap 63.04B
P/E 20.93
Div/yield 0.31/1.93
EPS 3.02
Shares 996.19M
Beta 1.06
Inst. own 88%
Aug 21, 2014
Medtronic Inc Annual Shareholders Meeting - 11:30AM EDT - Add to calendar
Aug 19, 2014
Q1 2015 Medtronic Inc. Earnings Release - 9:30AM EDT - Add to calendar
Aug 19, 2014
Q1 2015 Medtronic Inc Earnings Call - 8:00AM EDT - Add to calendar
Aug 6, 2014
Medtronic Inc at Piper Jaffray Heartland Summit(CEO's Perspective, Part 4) - 4:45PM EDT - Add to calendar
Aug 6, 2014
Medtronic Inc at Piper Jaffray Heartland Summit(CEO's Perspective, Part 1) - 11:30AM EDT - Add to calendar
Jun 17, 2014
Medtronic Inc at Wells Fargo Healthcare Conference - Webcast
Jun 16, 2014
Medtronic to Acquire Covidien Conference Call - Webcast
Jun 10, 2014
Medtronic Inc at Goldman Sachs Healthcare Conference - Webcast
Jun 5, 2014
Medtronic Inc. Analyst Meeting
May 20, 2014
Q4 2014 Medtronic Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '14) 2014
Net profit margin 9.81% 18.02%
Operating margin 10.76% 22.42%
EBITD margin - 33.33%
Return on average assets 4.78% 8.42%
Return on average equity 9.26% 16.08%
Employees 49,000 -
CDP Score - 61 D

Address

710 MEDTRONIC PKWY
MINNEAPOLIS, MN 55432
United States - Map
+1-763-5144000 (Phone)
+1-763-5144879 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Medtronic, Inc. (Medtronic) is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations.

Officers and directors

Omar Ishrak Chairman of the Board, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Gary L. Ellis Chief Financial Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Carol A. Surface Chief Human Resource Officer, Senior Vice President
Age: 48
Bio & Compensation  - Reuters
Michael J. Coyle Executive Vice President, Group President - Cardiac and Vascular Group
Age: 51
Bio & Compensation  - Reuters
Hooman C. Hakami Executive Vice President and Group President of the Medtronic Diabetes Group
Age: 44
Bio & Compensation  - Reuters
Robert ten Hoedt Executive Vice President and President, EMEAC
Age: 53
Bio & Compensation  - Reuters
Christopher J. O'Connell Executive Vice President and Group President - Restorative Therapies Group
Age: 47
Bio & Compensation  - Reuters
Richard E. Kuntz M.D. Senior Vice President, Chief Scientific, Clinical and Regulatory Officer
Age: 57
Bio & Compensation  - Reuters
Bradley E. Lerman Senior Vice President, General Counsel, Corporate secretary
Age: 57
Bio & Compensation  - Reuters
Geoffrey S. Martha Senior Vice President - Strategy and Business Development
Age: 44
Bio & Compensation  - Reuters